DEXTRAMER

Immudex ApS

Application Filed: 2009-12-28
Trademark Application Details
Trademark Logo DEXTRAMER
706
Live/Registered
SECTION 71 ACCEPTED
Research OneLook Acronym Finder
Serial Number79081953
Registration Number4040266
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic RepresentativeJulie A. Greenberg
Attorney NameJulie A. Greenberg
Attorney Docket Number67718-0016
Law Office AssignedM80
Employee NameORTIGA PALMER, RAMONA

Timeline

2009-12-28Application Filed
2011-08-02Published for Opposition
2011-10-18Trademark Registered
2017-06-09Location: GENERIC WEB UPDATE
2017-06-09Status: Live/Registered
2019-01-28Transaction Date

Trademark Applicants & Owners

Owner: Immudex ApS
Entity Statementlimited company
AddressFruebjergvej 3 DK-2100 København Ø DK
Legal Entity Type
Legal Entity State DK

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Julie A. Greenberg
Fishman Stewart PLLC
39533 Woodward Ave., Ste. 140
Bloomfield Hills MI 48304

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0051Preparations for pharmaceutical purposes, pharmaceutical preparations for medical purposes, and chemical-pharmaceutical preparations, namely vaccines and for treating infections caused by CMV, LCMV, EBV, HIV, HPV, BK polyomavirus, HTLV, Hepatitis B, Hepatitis C, TB, Graft versus Host Disease, Diabetes, JC Polyomavirus, HHV-3 (Human Herpes Virus), Influenza, Murine Herpes, Malaria, Murine Polyomavirus, RSV, HPV, Herpes Simplex Virus II, Sendai Virus, M Bovis, Vesicular Stromatitis Virus, Vaccinia Virus, Toxoplasmosis, Trypanosomacruzi, SIV, and vaccines and treatments for cancer, diabetes, arthritis, schlerosis, Achlorhydra Autoimmune Active Chronic Hepatitis, Acute Disseminated Encephalomyelitis, Acute hemorrhagic leukoencephalitis, Addison's Disease, Agammaglobulinemia, Alopecia areata, Amyotrophic Lateral Sclerosis, Ankylosing Spondylitis, Anti-GBM/TBM Nephritis, Antiphospholipid syndrome, Antisynthetase syndrome, Arthritis, Atopic allergy, Atopic Dermatitis, Autoimmune Aplastic Anemia, Autoimmune cardiomyopathy, Autoimmune hemolytic anemia, Autoimmune hepatitis, Autoimmune inner ear disease, Autoimmune lymphoproliferative syndrome, Autoimmune peripheral neuropathy, Autoimmune pancreatitis, Autoimmune polyendocrine syndrome Types I, II, and III, Autoimmune progesterone dermatitis, Autoimmune thrombocytopenic purpura, Autoimmune uveitis, Balo disease/Balo concentric sclerosis, Bechets Syndrome, Berger's disease, Bickerstaff's encephalitis, Blau syndrome, Bullous Pemphigoid, Castleman's disease, Chagas disease, Chronic Fatigue Immune Dysfunction Syndrome, Chronic antiflammatory demyelinating polyneuropathy, Chronic recurrent multifocal ostomyelitis, Chronic lyme disease, Chronic obstructive pulmonary disease, Churg-Strauss syndrome, CicatricialPemphigoid, Coeliac disease, Cogan syndrome, old agglutinin disease, Complement component 2 deficiency, Cranial arteritis, CREST syndrome, Crohns Disease, Cushing's Syndrome, Cutaneous leukocytoclasticangiitis, Dego's disease, Dercum's disease, Dermatitis herpetiformis, Dermatomyositis, Diabetes mellitus type 1, Diffuse cutaneous systemic sclerosis, Dressler's syndrome, Discoid lupus erythematosus, Eczema, Endometriosis, Enthesitis-related arthritis, Eosinophilic fasciitis, Epidermolysisbullosaacquisita, Erythema nodosum, Essential mixed cryoglobulinemia, Evan's syndrome, Fibrodysplasiaossificans progressive, Fibromyalgia, Fibromyositis, Fibrosingaveolitis, Gastritis, Gastrointestinal pemphigoid, Giant cell arteritis, Glomerulonephritis, Goodpasture's syndrome, Graves' disease, Guillain-Barré syndrome (GBS), Hashimoto's encephalitis, Hashimoto's thyroiditis, Haemolyticanemia, Henoch-Schonleinpurpura, Herpes gestationis, Hidradenitissuppurativa, Hughes syndrome, Hypogammaglobulinemia, Idiopathic Inflammatory Demyelinating Diseases, Idiopathic pulmonary fibrosis, Idiopathic thrombocytopenic purpura, IgA nephropathy (Berger's disease), Inclusion body myositis, Inflammatory demyelinating , olyneuopathy, Interstitial cystitis, Irritable Bowel Syndrome (IBS), Juvenile idiopathic arthritis, Juvenile heumatoid arthritis, Kawasaki's Disease, Lambert-Eaton myasthenic syndrome, Leukocytoclasticvasculitis, Lichen planus, Lichen sclerosus, Linear IgA disease (LAD), Lou Gehrig's Disease (Amyotrophic lateral sclerosis), Lupoid hepatitis, Lupus erythematosus, Majeed syndrome, Ménière's disease, Microscopic, polyangiitis, Miller-Fisher syndrome, Mixed Connective Tissue Disease, Morphea, Mucha-Habermann disease, Muckle-Wells syndrome, Multiple Myeloma, Multiple Sclerosis, Myasthenia gravis, Myositis, Narcolepsy, Neuromyelitisoptica(Devic's Disease), Neuromyotonia, Occularcicatricialpemphigoid, Opsoclonus myoclonus syndrome, Ord's thyroiditis, Palindromic rheumatism, PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus), Paraneoplastic cerebellar degeneration, Paroxysmal nocturnal hemoglobinuria (PNH), Parry Romberg syndrome, Parsonnage-Turner syndrome, Pars planitis, Pemphigus, Pemphigus vulgaris, Pernicious anaemia, Perivenous encephalomyelitis, POEMS syndrome, Polyarteritisnodosa, Polymyalgia rheumatic, Polymyositis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Progressive inflammatory neuropathy, Psoriasis, Psoriatic Arthritis,Pyodermagangrenosum, Pure red cell aplasia, Rasmussen's encephalitis, Raynaud phenomenon, Relapsing polychondritis, Reiter's syndrome, Restless leg syndrome, Retroperitoneal fibrosis, Rheumatoid arthritis, Rheumatoid fever, Sarcoidosis, Schizophrenia, Schmidt syndrome, Schnitzler syndrome, Scleritis, Scleroderma, Sjögren's syndrome, Spondyloarthropathy, Sticky blood syndrome, Still's Disease, Stiff person syndrome, Subacute bacterial endocarditis (SBE), Susac's syndrome, Sweet syndrome, Sydenham Chorea, Sympathetic ophthalmia, Takayasu's arteritis, Temporal arteritis (giant cell arteritis), Tolosa-Hunt syndrome, Transverse Myelitis, Ulcerative Colitis, Undifferentiated connective tissue disease, Undifferentiated spondyloarthropathy, Vasculitis, Vitiligo, Wegener's granulomatosis, Wilson's syndrome, Wiskott-Aldrich syndrome, T-cell lymphoma, and T-cell infiltration of solid tumors and tissue; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes and for research, preparations for analysis for medical and research purposes, hereunder for each of the abovementioned preparations for development and analysis of vaccines and treatments targeting infections by CMV, LCMV, EBV, HIV, HPV, BK polyomavirus, HTLV, Hepatitis B, Hepatitis C, TB, Graft versus Host Disease, Diabetes, JC Polyomavirus, HHV-3 (Human Herpes Virus), Influenza, Murine Herpes, Malaria, Murine Polyomavirus, RSV, HPV, Herpes Simplex Virus II, Sendai Virus, M Bovis, Vesicular Stromatitis Virus, Vaccinia Virus, Toxoplasmosis, Trypanosomacruzi, SIV, and vaccines and treatments for cancer, diabetes, arthritis, schlerosis, Achlorhydra Autoimmune Active Chronic Hepatitis, Acute Disseminated Encephalomyelitis, Acute hemorrhagic leukoencephalitis, Addison's Disease, Agammaglobulinemia, Alopecia areata, Amyotrophic Lateral Sclerosis, Ankylosing Spondylitis, Anti-GBM/TBM Nephritis, Antiphospholipid syndrome, Antisynthetase syndrome, Arthritis, Atopic allergy, Atopic Dermatitis, Autoimmune Aplastic Anemia, Autoimmune cardiomyopathy, Autoimmune hemolytic anemia, Autoimmune hepatitis, Autoimmune inner ear disease, Autoimmune lymphoproliferative syndrome, Autoimmune peripheral neuropathy, Autoimmune pancreatitis, Autoimmune polyendocrine syndrome Types I, II, and III, Autoimmune progesterone dermatitis, Autoimmune thrombocytopenic purpura, Autoimmune uveitis, Balo disease/Balo concentric sclerosis, Bechets Syndrome, Berger's disease, Bickerstaff's encephalitis, Blau syndrome, Bullous Pemphigoid, Castleman's disease, Chagas disease, Chronic Fatigue Immune Dysfunction Syndrome, Chronic inflammatory demyelinating polyneuropathy, Chronic recurrent multifocal ostomyelitis, Chronic lyme disease, Chronic obstructive pulmonary disease, Churg-Strauss syndrome, CicatricialPemphigoid, Coeliac disease, Cogan syndrome, old agglutinin disease, Complement component 2 deficiency, Cranial arteritis, CREST syndrome, Crohns Disease, Cushing's Syndrome, Cutaneous leukocytoclasticangiitis, Dego's disease, Dercum's disease, Dermatitis herpetiformis, Dermatomyositis, Diabetes mellitus type 1, Diffuse cutaneous systemic sclerosis, Dressler's syndrome, Discoid lupus erythematosus, Eczema, Endometriosis, Enthesitis-related arthritis, Eosinophilic fasciitis, Epidermolysisbullosaacquisita, Erythema nodosum, Essential mixed cryoglobulinemia, Evan's syndrome, Fibrodysplasiaossificans progressive, Fibromyalgia, Fibromyositis, Fibrosingaveolitis, Gastritis, Gastrointestinal pemphigoid, Giant cell arteritis, Glomerulonephritis, Goodpasture's syndrome, Graves' disease, Guillain-Barré syndrome (GBS), Hashimoto's encephalitis, Hashimoto's thyroiditis, Haemolytic anemia,Henoch-Schonleinpurpura, Herpes gestationis, Hidradenitissuppurativa, Hughes syndrome, Hypogammaglobulinemia, Idiopathic Inflammatory Demyelinating Diseases, Idiopathic pulmonary fibrosis, Idiopathic thrombocytopenic purpura, IgA nephropathy (Berger's disease), Inclusion body myositis, Inflammatory demyelinating, olyneuopathy, Interstitial cystitis, Irritable Bowel Syndrome (IBS), Juvenile idiopathic arthritis, Juvenile heumatoid arthritis, Kawasaki's Disease, Lambert-Eaton myasthenic syndrome, Leukocytoclasticvasculitis, Lichen planus, Lichen sclerosus, Linear IgA disease (LAD), Lou Gehrig's Disease (Amyotrophiclateral sclerosis), Lupoid hepatitis, Lupus erythematosus, Majeed syndrome, Ménière's disease, Microscopic polyangiitis, Miller-Fisher syndrome, Mixed Connective Tissue Disease, Morphea, Mucha-Habermann disease, Muckle-Wells syndrome, Multiple Myeloma, Multiple Sclerosis, Myasthenia gravis, Myositis, Narcolepsy, Neuromyelitisoptica (Devic's Disease), Neuromyotonia, Occularcicatricialpemphigoid, Opsoclonus myoclonus syndrome, Ord's thyroiditis, Palindromic rheumatism, PANDAS (Pediatric autoimmune Neuropsychiatric Disorders Associated withStreptococcus), Paraneoplastic cerebellar degeneration, Paroxysmal nocturnal hemoglobinuria (PNH), Parry Romberg syndrome, Parsonnage-Turner syndrome, Pars planitis, Pemphigus, Pemphigus vulgaris, Pernicious anaemia, Perivenous encephalomyelitis, POEMS syndrome, Polyarteritisnodosa, Polymyalgia rheumatic, Polymyositis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Progressive inflammatory neuropathy, Psoriasis, Psoriatic Arthritis, Pyodermagangrenosum, Pure red cell aplasia, Rasmussen's encephalitis, Raynaud phenomenon, Relapsingpolychondritis, Reiter's syndrome, Restless leg syndrome, Retroperitoneal fibrosis, Rheumatoid arthritis, Rheumatoid fever, Sarcoidosis, Schizophrenia, Schmidt syndrome, Schnitzler syndrome, Scleritis, Scleroderma, Sjögren's syndrome, Spondyloarthropathy, Sticky blood syndrome, Still's Disease, Stiff person syndrome, Subacute bacterial endocarditis (SBE), Susac's syndrome, Sweet syndrome, Sydenham Chorea, Sympathetic ophthalmia, Takayasu's arteritis, Temporal arteritis (giant cell arteritis), Tolosa-Hunt syndrome, Transverse Myelitis, Ulcerative Colitis, Undifferentiated connective tissue disease, Undifferentiated spondyloarthropathy, Vasculitis, Vitiligo, Wegener's granulomatosis, Wilson's syndrome, Wiskott-Aldrich syndrome, T-cell lymphoma, and T-cell infiltration of solid tumors and tissue, and for use in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T-cell monitoring

Trademark Filing History

DescriptionDateEvent Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB2010-05-201 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2010-05-222 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2010-05-223 DOCK D:Assigned to Examiner
APPLICATION FILING RECEIPT MAILED2010-05-264 MAFR O:Outgoing Correspondence
NON-FINAL ACTION WRITTEN2010-05-295 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2010-05-306 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU2010-06-017 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2010-06-018 RFCS P:
REFUSAL PROCESSED BY IB2010-07-029 RFNT P:
CORRECTION TRANSACTION RECEIVED FROM IB2010-07-3010 CRCV M:
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED2010-08-0511 CORR I:Incoming Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2010-12-0112 TROA I:Incoming Correspondence
ASSIGNED TO LIE2010-12-2813 ALIE A:Allowance for Publication
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2010-12-2814 CHAN I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2010-12-2815 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2010-12-2816 TEME I:Incoming Correspondence
NON-FINAL ACTION WRITTEN2011-01-2317 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2011-01-2318 GNRT O:Outgoing Correspondence
NOTIFICATION OF NON-FINAL ACTION E-MAILED2011-01-2319 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2011-05-2520 TROA I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2011-05-2521 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2011-05-2522 ARAA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2011-05-2523 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2011-06-0824 TEME I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2011-06-0825 CHAN I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2011-06-2126 CNSA O:Outgoing Correspondence
LAW OFFICE PUBLICATION REVIEW COMPLETED2011-06-2927 PREV O:Outgoing Correspondence
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB2011-07-1328 OP2R P:
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB2011-07-1329 OPNS P:
PUBLISHED FOR OPPOSITION2011-08-0230 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2011-08-0231 NPUB E:E-Mail
NOTIFICATION PROCESSED BY IB2011-10-0232 GPNX P:
REGISTERED-PRINCIPAL REGISTER2011-10-1833 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB2012-01-1834 FICR P:
FINAL DISPOSITION PROCESSED2012-05-3035 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB2012-05-3036 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB2012-06-1537 FINO P:
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED2016-10-1838 REM3 E:E-Mail
NEW REPRESENTATIVE AT IB RECEIVED2016-12-2239 NREP P:
TEAS CHANGE OF CORRESPONDENCE RECEIVED2017-02-1540 TCCA I:Incoming Correspondence
TEAS SECTION 71 RECEIVED2017-02-1541 ES71 I:Incoming Correspondence
NEW REPRESENTATIVE AT IB RECEIVED2017-03-0242 NREP P:
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2017-06-0843 APRE A:Allowance for Publication
REGISTERED-SEC.71 ACCEPTED2017-06-0944 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED2017-06-0945 NA71 E:E-Mail
NEW REPRESENTATIVE AT IB RECEIVED2017-08-3146 NREP P:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-01-2547 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-01-2548 ARAA I:Incoming Correspondence
INTERNATIONAL REGISTRATION RENEWED2020-01-1649 RNWL P:
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED2020-10-1850 REM4 E:E-Mail
TEAS CHANGE OF OWNER ADDRESS RECEIVED2021-07-1251 COAR I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2021-07-1252 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2021-07-1253 ARAA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED2021-07-1254 TCCA I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2021-07-1255 CHAN I:Incoming Correspondence
TEAS SECTION 71 RECEIVED2021-09-2856 ES71 I:Incoming Correspondence
CHANGE OF NAME/ADDRESS REC'D FROM IB2022-01-2157 ADCH M:
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2022-04-2758 APRE A:Allowance for Publication
REGISTERED-SEC.71 ACCEPTED2022-05-2859 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED2022-05-2860 NA71 E:E-Mail
NEW REPRESENTATIVE AT IB RECEIVED2023-04-0261 NREP P:
TEAS CHANGE OF OWNER ADDRESS RECEIVED2023-04-1462 COAR I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2023-04-1463 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2023-04-1464 ARAA I:Incoming Correspondence
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS2023-04-1465 ECDR I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED2023-04-1466 TCCA I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2023-04-1467 CHAN I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed